Medicine Man Technologies Inc
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products … Read more
Medicine Man Technologies Inc (SHWZ) - Net Assets
Latest net assets as of June 2024: $90.79 Million USD
Based on the latest financial reports, Medicine Man Technologies Inc (SHWZ) has net assets worth $90.79 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($339.61 Million) and total liabilities ($248.82 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $90.79 Million |
| % of Total Assets | 26.73% |
| Annual Growth Rate | 95.24% |
| 5-Year Change | 348.8% |
| 10-Year Change | N/A |
| Growth Volatility | 104.12 |
Medicine Man Technologies Inc - Net Assets Trend (2014–2023)
This chart illustrates how Medicine Man Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medicine Man Technologies Inc (2014–2023)
The table below shows the annual net assets of Medicine Man Technologies Inc from 2014 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $119.29 Million | -9.74% |
| 2022-12-31 | $132.16 Million | -1.05% |
| 2021-12-31 | $133.57 Million | +219.74% |
| 2020-12-31 | $41.77 Million | +57.17% |
| 2019-12-31 | $26.58 Million | +55.68% |
| 2018-12-31 | $17.07 Million | +58.99% |
| 2017-12-31 | $10.74 Million | +2953.69% |
| 2016-12-31 | $-376.33K | -182.70% |
| 2015-12-31 | $455.05K | +57.14% |
| 2014-12-31 | $289.58K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Medicine Man Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 8076097300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $74.89K | 0.06% |
| Other Comprehensive Income | $-86.00 | 0.00% |
| Other Components | $200.01 Million | 167.66% |
| Total Equity | $119.29 Million | 100.00% |
Medicine Man Technologies Inc Competitors by Market Cap
The table below lists competitors of Medicine Man Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MEDIMI AB AK
F:79T
|
$341.57K |
|
Transforma Resources Corp
V:TFM
|
$341.87K |
|
Composite Alliance Group Inc
V:CAG
|
$341.97K |
|
Tortoise Capital Series Trust
NYSE:TCAI
|
$342.03K |
|
enX Group Ltd
JSE:ENX
|
$341.21K |
|
PIEQ
BATS:PIEQ
|
$340.65K |
|
Global Knafaim Leasing Ltd
TA:GKL
|
$340.63K |
|
Boosh Plant-Based Brands Inc
OTCQB:VGGIF
|
$340.45K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medicine Man Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 132,163,371 to 119,291,888, a change of -12,871,483 (-9.7%).
- Net loss of 34,549,344 reduced equity.
- Share repurchases of 108,978 reduced equity.
- Other comprehensive income decreased equity by 86.
- Other factors increased equity by 21,786,925.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-34.55 Million | -28.96% |
| Share Repurchases | $108.98K | -0.09% |
| Other Comprehensive Income | $-86.00 | -0.0% |
| Other Changes | $21.79 Million | +18.26% |
| Total Change | $- | -9.74% |
Book Value vs Market Value Analysis
This analysis compares Medicine Man Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.19x to 0.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.03 | $0.01 | x |
| 2015-12-31 | $0.05 | $0.01 | x |
| 2016-12-31 | $-0.04 | $0.01 | x |
| 2017-12-31 | $0.47 | $0.01 | x |
| 2018-12-31 | $0.61 | $0.01 | x |
| 2019-12-31 | $0.79 | $0.01 | x |
| 2020-12-31 | $1.01 | $0.01 | x |
| 2021-12-31 | $3.08 | $0.01 | x |
| 2022-12-31 | $2.46 | $0.01 | x |
| 2023-12-31 | $1.85 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medicine Man Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -28.96%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -20.03%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 3.00x
- Recent ROE (-28.96%) is below the historical average (-17.85%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -10.34% | -11.89% | 0.81x | 1.08x | $-58.91K |
| 2015 | 18.84% | 10.26% | 1.75x | 1.05x | $40.24K |
| 2016 | 0.00% | -231.89% | 0.87x | 0.00x | $-1.43 Million |
| 2017 | -50.11% | -152.46% | 0.32x | 1.04x | $-6.46 Million |
| 2018 | 5.56% | 11.97% | 0.43x | 1.07x | $-758.46K |
| 2019 | -63.87% | -159.87% | 0.33x | 1.21x | $-19.63 Million |
| 2020 | -46.48% | -80.90% | 0.34x | 1.69x | $-23.59 Million |
| 2021 | 10.87% | 13.39% | 0.38x | 2.13x | $1.16 Million |
| 2022 | -13.97% | -11.59% | 0.49x | 2.44x | $-31.68 Million |
| 2023 | -28.96% | -20.03% | 0.48x | 3.00x | $-46.48 Million |
Industry Comparison
This section compares Medicine Man Technologies Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medicine Man Technologies Inc (SHWZ) | $90.79 Million | -10.34% | 2.74x | $341.36K |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |